Literature DB >> 20219897

HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice.

Masataka Tsuge1, Nobuhiko Hiraga, Rie Akiyama, Sachi Tanaka, Miyuki Matsushita, Fukiko Mitsui, Hiromi Abe, Shosuke Kitamura, Tsuyoshi Hatakeyama, Takashi Kimura, Daiki Miki, Nami Mori, Michio Imamura, Shoichi Takahashi, C Nelson Hayes, Kazuaki Chayama.   

Abstract

The non-structural X protein, HBx, of hepatitis B virus (HBV) is assumed to play an important role in HBV replication. Woodchuck hepatitis virus X protein is indispensable for virus replication, but the duck hepatitis B virus X protein is not. In this study, we investigated whether the HBx protein is indispensable for HBV replication in vivo using human hepatocyte chimeric mice. HBx-deficient (HBx-def) HBV was generated in HepG2 cells by transfection with an overlength HBV genome. Human hepatocyte chimeric mice were infected with HBx-def HBV with or without hepatic HBx expression by hydrodynamic injection of HBx expression plasmids. Serum virus levels and HBV sequences were determined with mice sera. The generated HBx-def HBV peaked in the sucrose density gradient at points equivalent to the generated HBV wild type and the virus in a patient's serum. HBx-def HBV-injected mice developed measurable viraemia only in continuously HBx-expressed liver. HBV DNA in the mouse serum increased up to 9 log(10) copies ml(-1) and the viraemia persisted for more than 2 months. Strikingly, all revertant viruses had nucleotide substitutions that enabled the virus to produce the HBx protein. It was concluded that the HBx protein is indispensable for HBV replication and could be a target for antiviral therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20219897     DOI: 10.1099/vir.0.019224-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  51 in total

1.  Hepatitis: Epigenetic control of HBV by HBx protein--releasing the break?

Authors:  Ulrike Protzer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-01       Impact factor: 46.802

2.  Hepatitis B virus molecular biology and pathogenesis.

Authors:  R Jason Lamontagne; Sumedha Bagga; Michael J Bouchard
Journal:  Hepatoma Res       Date:  2016-07-01

3.  The hepatitis B virus X protein elevates cytosolic calcium signals by modulating mitochondrial calcium uptake.

Authors:  Bei Yang; Michael J Bouchard
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

Review 4.  The current status and future directions of hepatitis B antiviral drug discovery.

Authors:  Liudi Tang; Qiong Zhao; Shuo Wu; Junjun Cheng; Jinhong Chang; Ju-Tao Guo
Journal:  Expert Opin Drug Discov       Date:  2016-11-11       Impact factor: 6.098

Review 5.  Experimental models and therapeutic approaches for HBV.

Authors:  Maura Dandri; Marc Lütgehetmann; Jörg Petersen
Journal:  Semin Immunopathol       Date:  2012-08-17       Impact factor: 9.623

6.  Reactive Oxygen Species-Mediated c-Jun NH2-Terminal Kinase Activation Contributes to Hepatitis B Virus X Protein-Induced Autophagy via Regulation of the Beclin-1/Bcl-2 Interaction.

Authors:  Linmao Zhong; Wangqin Shu; Wangbin Dai; Bo Gao; Sidong Xiong
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

Review 7.  Technical standards for hepatitis B virus X protein (HBx) research.

Authors:  Betty L Slagle; Ourania M Andrisani; Michael J Bouchard; Caroline G L Lee; J-H James Ou; Aleem Siddiqui
Journal:  Hepatology       Date:  2015-03-09       Impact factor: 17.425

Review 8.  Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential.

Authors:  Maura Dandri; Joerg Petersen
Journal:  Clin Infect Dis       Date:  2016-06-01       Impact factor: 9.079

Review 9.  Hepatitis B Virus X and Regulation of Viral Gene Expression.

Authors:  Betty L Slagle; Michael J Bouchard
Journal:  Cold Spring Harb Perspect Med       Date:  2016-01-08       Impact factor: 6.915

Review 10.  Role of HBx in hepatitis B virus persistence and its therapeutic implications.

Authors:  Betty L Slagle; Michael J Bouchard
Journal:  Curr Opin Virol       Date:  2018-02-20       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.